| P2093 | author name string | Yasuyoshi Ueki | |
| | Teruhito Yoshitaka | |
| | Tetsuya Yoshimoto | |
| | Tomoyuki Mukai | |
| | Kotoe Mayahara | |
| | Mizuho Kittaka | |
| | Jeffrey P Gorski | |
| P2860 | cites work | Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism | Q24299210 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate | Q24658507 |
| | Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 |
| | Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils | Q28308243 |
| | SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase | Q28364720 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice | Q41825949 |
| | Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis | Q42137135 |
| | c-Fos-deficient mice are susceptible to Salmonella enterica serovar Typhimurium infection | Q42913373 |
| | Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism | Q42918583 |
| | Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 |
| | Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects | Q43833399 |
| | BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice | Q44196757 |
| | Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease | Q44334690 |
| | The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. | Q44431651 |
| | Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells | Q45149864 |
| | Forced expression of stabilized c-Fos in dendritic cells reduces cytokine production and immune responses in vivo | Q45352583 |
| | Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A | Q46979889 |
| | Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. | Q51997176 |
| | Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. | Q53323334 |
| | Tartrate-resistant acid phosphatase is not an exclusive marker for mouse osteoclasts in cell culture. | Q54304218 |
| | c-Fos suppresses systemic inflammatory response to endotoxin | Q57675135 |
| | Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation | Q57675158 |
| | c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 |
| | Bone and haematopoietic defects in mice lacking c-fos | Q58326969 |
| | The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 |
| | Pleiotropic effects of a null mutation in the c-fos proto-oncogene | Q62555352 |
| | Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis | Q72201830 |
| | Rheumatoid arthritis associated with osteopetrosis | Q84355554 |
| | Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 |
| | SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 | Q29620495 |
| | SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss | Q30009398 |
| | Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children. | Q30009992 |
| | NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism | Q30157499 |
| | Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism | Q30168144 |
| | Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis | Q33561675 |
| | Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties | Q33787888 |
| | Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment | Q33896725 |
| | Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth | Q34190659 |
| | R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation | Q34562439 |
| | MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products | Q34756212 |
| | Osteoclasts are essential for TNF-alpha-mediated joint destruction | Q34826003 |
| | Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. | Q34942166 |
| | Cell surface collagenolysis requires homodimerization of the membrane-bound collagenase MT1-MMP | Q35191039 |
| | Giant cell tumour of bone: new treatments in development | Q35662668 |
| | TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis | Q35788463 |
| | Bone loss in inflammatory arthritis: mechanisms and treatment strategies | Q35808004 |
| | Bisphosphonate therapy in rheumatoid arthritis | Q36450042 |
| | Matrix metalloproteinase dependent and independent collagen degradation | Q36486724 |
| | Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade | Q36536688 |
| | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review | Q37158791 |
| | Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. | Q37163219 |
| | Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 |
| | Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both? | Q37415061 |
| | Osteoimmunology and the effects of the immune system on bone | Q37626412 |
| | Bone remodeling in rheumatic disease: a question of balance | Q37700811 |
| | Osteopetrosis: genetics, treatment and new insights into osteoclast function. | Q38123371 |
| | Viewpoints on vessels and vanishing bones in Gorham-Stout disease | Q38192380 |
| | The role of tumour-associated macrophages in bone metastasis | Q38985682 |
| | Direct Resorption of Bone by Human Monocytes | Q39146302 |
| | Rodent peritoneal macrophages as bone resorbing cells | Q39687752 |
| | SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling | Q40489357 |
| | The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen | Q40513100 |
| | Osteoclasts, macrophages, and the molecular mechanisms of bone resorption | Q41431482 |
| | Development, differentiation, and maturation of macrophages in the fetal mouse liver | Q41728725 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 167-181 | |
| P577 | publication date | 2017-09-15 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts | |
| P478 | volume | 33 | |